Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Regeneron Pharmaceuticals, Inc. > Profile

Instuitional Investor - Regeneron Pharmaceuticals, Inc.

Fund Profile
Filing Period:
Fund Name: Regeneron Pharmaceuticals, Inc.
Portfolio Value $700,444,832
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Alnylam Pharmaceuticals Inc.
 ALNY 1,392,303 $634,890,168 90.64%
2.
Intellia Therapeutics Inc.
 NTLA 3,702,995 $63,950,724 9.13%
3.
Adverum Biotechnologies Inc.
 ADVM 180,909 $819,518 0.12%
4.
Adicet Bio Inc.
 ACET 968,183 $784,422 0.11%
Insider Monkey Quarterly Strategy
+427.7% Insider Monkey Quarterly Strategy
+163.1% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
400%
200%
0%

Returns since its inception in May 2014 (through August 15th, 2025)

Subscribe Now

30 day money back guarantee. Cancel anytime.